Related references
Note: Only part of the references are listed.Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats
Ernesto Martinez-Martinez et al.
JOURNAL OF HYPERTENSION (2018)
The association between oxidative stress-induced galectins and differentiation of human promyelocytic HL-60 cells
James R. Vinnai et al.
EXPERIMENTAL CELL RESEARCH (2017)
Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model
Jaime Ibarrola et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation
Isabel Fort-Gallifa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts
Ernesto Martinez-Martinez et al.
JOURNAL OF PROTEOMICS (2017)
Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4
Jingni He et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2017)
Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts
Ernesto Martinez-Martinez et al.
SCIENTIFIC REPORTS (2017)
Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development
Carlos-Ernesto Fernandez-Garcia et al.
CLINICAL SCIENCE (2017)
A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis
Vanessa Arrieta et al.
CLINICAL SCIENCE (2017)
Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy
Wen-qian Dong et al.
ONCOTARGET (2016)
Mitochondrial dynamics, mitophagy and cardiovascular disease
Cesar Vasquez-Trincado et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage
Ernesto Martinez-Martinez et al.
PLOS ONE (2016)
Role for Galectin-3 in Calcific Aortic Valve Stenosis
J. Rafael Sadaba et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
New insights into redox regulation of stem cell self-renewal and differentiation
Fenglian Ren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and Hypertension
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
Ernesto Martinez-Martinez et al.
HYPERTENSION (2015)
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Laurent Calvier et al.
JACC-HEART FAILURE (2015)
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial
Frank Edelmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Short-term use of telmisartan attenuates oxidation and improves Prdx2 expression more than antioxidant β-blockers in the cardiovascular systems of spontaneously hypertensive rats
Sae Mi Yoo et al.
HYPERTENSION RESEARCH (2015)
The Prognostic Value of Plasma Galectin-3 in Chronic Heart Failure Patients Is Maintained when Treated with Mineralocorticoid Receptor Antagonists
Francois Koukoui et al.
PLOS ONE (2015)
Hypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis
Joana T. de Oliveira et al.
PLOS ONE (2015)
Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity
Ernesto Martinez-Martinez et al.
JOURNAL OF HYPERTENSION (2014)
Galectin-3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis
Julio Madrigal-Matute et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Laurent Calvier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
Natasha Fillmore et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression
Yuan-Guo Wang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Role of reactive nitrogen species generated via inducible nitric oxide synthase in vesicant-induced lung injury, inflammation and altered lung functioning
Vasanthi R. Sunil et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All-Cause Mortality
Ali Abbasi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
Rudolf A. de Boer et al.
ANNALS OF MEDICINE (2011)
Reactive oxygen species in cardiovascular disease
Koichi Sugamura et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Overexpression of Peroxiredoxin 4 Protects Against High-Dose Streptozotocin-Induced Diabetes by Suppressing Oxidative Stress and Cytokines in Transgenic Mice
Yan Ding et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis
Wen Zhao et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Mitochondrial oxidative stress and dysfunction in myocardial remodelling
Hiroyuki Tsutsui et al.
CARDIOVASCULAR RESEARCH (2009)
Prohibitin protects against oxidative stress-induced cell injury in cultured neonatal cardiomyocyte
XiaoHua Liu et al.
CELL STRESS & CHAPERONES (2009)
Typical 2-Cys peroxiredoxins - structures, mechanisms and functions
Andrea Hall et al.
FEBS JOURNAL (2009)
Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis
Janka Kisucka et al.
CIRCULATION RESEARCH (2008)
Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension - What is the clinical significance?
RM Touyz
HYPERTENSION (2004)
Share Paper
